Abbott Adding Nutritional For Consumers Using Type 2 Diabetes, Weight Management Drugs

Ensure and Glucerna brand and other adult product sales up 12.5% to account for $1.05bn of $2.04bn in total Q4 nutritionals sales; full-year adult product sales up 6.2%, accounting for $4.2bn of Abbott’s $8.15bn in total nutritionals sales.

• Source: Shutterstock

Adult products led Abbott ’s nutritional business sales growth in 2023 and likely will become a stronger driver in 2024 with the launch of a formulation for people using medications rapidly growing in popularity with the addition of a weight loss indication.

Sales of Abbott’s Ensure and Glucerna brands accounted for $1.05bn of the firm’s $2.04bn in total nutritionals sales for the fourth quarter, with adult product sales up 12.5% from the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Earnings

More from Business